Skip to Content

Notice

CDC Advisory Committee on HIV and STD Prevention: Meeting

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the following committee meeting. Start Printed Page 70571

Name: CDC Advisory Committee on HIV and STD Prevention.

Times and Dates: 8:30 a.m.-5 p.m., December 14, 2000; 8:30 a.m.-3 p.m., December 15, 2000.

Place: Corporate Square Office Park, Corporate Square

Boulevard, Building 8, 1st Floor Conference Room, Atlanta,

Georgia 30329.

Status: Open to the public, limited only by the space available. The meeting room will accommodate approximately 100 people.

Purpose: This Committee is charged with advising the Director, CDC, regarding objectives, strategies, and priorities for HIV and STD prevention efforts including maintaining surveillance of HIV infection, AIDS, and STDs, the epidemiologic and laboratory study of HIV/AIDS and STDs, information/education and risk reduction activities designed to prevent the spread of HIV and STDs, and other preventive measures that become available.

Matters to be Discussed: Agenda items include issues pertaining to (1) national HIV prevention plan, (2) national syphilis elimination efforts, (3) recent trends in STD and HIV Morbidity and Risk Behaviors among MSM, and (4) issues pertaining to the IOM report on HIV Prevention. Agenda items are subject to change as priorities dictate.

Contact Person for More Information: Paulette Ford, Committee Management Specialist, National Center for HIV, STD, and TB Prevention, 1600 Clifton Road, NE, Mailstop E-07, Atlanta, Georgia 30333. Telephone 404/639-8008, fax 404/639-8600, e-mail pbf7@cdc.gov.

The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register Notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.

Start Signature

Julia M. Fuller,

Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.

End Signature End Preamble

[FR Doc. 00-30018 Filed 11-22-00; 8:45 am]

BILLING CODE 4163-18-P